Assessment of Pharmacy Closures in the United States from 2009 Through 2015

TY - JOUR

T1 - Assessment of Pharmacy Closures in the United States from 2009 Through 2015

AU - Guadamuz, Jenny S.

AU - Alexander, G. Caleb

AU - Zenk, Shannon N.

AU - Qato, Dima M.

N1 - Funding Information: Conflict of Interest Disclosures: Ms Guadamuz reports receiving grants from the Robert Wood Johnson Foundation Health Policy Research Scholar program and grants from the National Heart, Lung, and Blood Institute (T32-HL125294). Dr Alexander reports being the former chair of the US Food and Drug Administration’s Peripheral and Central Nervous System Advisory Committee; serving as a paid advisor to IQVIA; holding equity in Monument Analytics, a health care consultancy whose clients include the life sciences industry and plaintiffs in opioid litigation; and being a member of OptumRx’s National P&T Committee. This arrangement has been reviewed and approved by Johns Hopkins University in accordance with its conflict of interest policies. Dr Qato reports being a paid consultant for Public Citizen’s Health Research Group, has received funding from Blue Cross Blue Shield and Cardinal Health, is supported in part by grants from the Robert Wood Johnson Foundation as part of the Clinical Scholars Leadership program, and is a fellow of the National Academy of Medicine. No other disclosures are reported. Funding/Support: This work was supported by the National Institutes of Health’s National Institute on Aging (R21AG04923). Funding Information: Conflict of Interest Disclosures: Dr Mangurian reports research grants from the National Institute of Mental Health (R01MH112420), the Doris Duke Charitable Fund Foundation, and the California Health Care Foundation; reports speaker fees from American Academy of Pediatrics, Uncommon Bold, and American Psychiatric Association outside the submitted work; and is a founding member of TIME’S UP Healthcare but receives no financial compensation through this role. Dr Jagsi reports grants from National Institutes of Health, Doris Duke Charitable Fund Foundation, Susan G. Komen for the Cure, Greenwall Foundation, and Blue Cross Blue Shield of Michigan for the Michigan Radiation Oncology Quality Consortium; personal fees from Amgen, Vizient, and Greenwall Foundation; and stock options as compensation for her advisory board role in Equity Quotient outside the submitted work. Dr Choo reports being a cofounder of Equity Quotient outside the submitted work; serves as an unpaid volunteer for FeminEM.org, Gender Equity in Medicine Research Foundation, TIME’S UP Healthcare, and the TIME’S UP Foundation; reports grants from the National Institutes of Health (1R01DA047323-01) and the Insurance Institute for Highway Safety. Dr Hsia reports grants from the National Heart, Lung, and Blood Institute (R01HL114822 and R01HL134182) for unrelated work. No other disclosures were reported.

PY - 2020/1

Y1 - 2020/1

UR - http://www.scopus.com/inward/record.url?scp=85073755234&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073755234&partnerID=8YFLogxK

U2 - 10.1001/jamainternmed.2019.4588

DO - 10.1001/jamainternmed.2019.4588

M3 - Letter

C2 - 31633745

AN - SCOPUS:85073755234

SN - 2168-6106

VL - 180

SP - 157

EP - 160

JO - JAMA internal medicine

JF - JAMA internal medicine

IS - 1

ER -